Objective Different regional specificity in tau accumulation is well known in Alzheimer’s disease (AD) brains. However, little is known about such distribution in aging brains and mild cognitive impairment (MCI) brains.Methods Cognitive functions and regional accumulation of tau and amyloid (A) were evaluated in 13 healthy controls (HCs), 3 patients with MCI, and 4 AD patients. Tau and A accumulation was semi-quantitatively measured with positron emission tomography (PET) using [11C]pyridinyl-butadienyl-benzothiazole 3 (PBB3) and [11C]Pittsburgh compound-B (PiB).Results Age-dependent accumulation of tau was found in all predetermined regions characteristic of AD, especially in the parahippocampal gyrus, lateral temporal cortex, frontal cort...
BackgroundClinical staging of Alzheimer disease (AD) may help develop novel treatment in the early s...
The recent development of tau-specific positron emission tomography (PET) tracers enables in vivo qu...
Tau PET enables in vivo visualization and quantitation of tau accumulation in Alzheimer disease (AD)...
Tau pathology is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive aging. U...
Background and aims:Senile plaques and deposition of intracellular tau fibrils are neuropathological...
Tau pathology is a hallmark of Alzheimer’s disease (AD) but also occurs in normal cognitive aging. U...
Tau pathology is a hallmark of Alzheimer’s disease (AD) but also occurs in normal cognitive aging. U...
Background and aims:[11C]PBB3 is a novel tau imaging PET ligand, showing high affinity and selectivi...
INTRODUCTION:Amyloid-β (Aβ) and tau accumulations may occur independently and concurrently as exempl...
In addition to the deposition of β-amyloid plaques, neurofibrillary tangles composed of aggregated h...
Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pat...
Background: Amyloid-beta (Aβ) is hypothesized to facilitate the spread of tau pathology beyond the m...
Amyloid-β (Aβ) is hypothesized to facilitate the spread of tau pathology beyond the medial temporal ...
Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pat...
Background:We previously reported that among cases clinically diagnosed with Alzheimer’s disease, th...
BackgroundClinical staging of Alzheimer disease (AD) may help develop novel treatment in the early s...
The recent development of tau-specific positron emission tomography (PET) tracers enables in vivo qu...
Tau PET enables in vivo visualization and quantitation of tau accumulation in Alzheimer disease (AD)...
Tau pathology is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive aging. U...
Background and aims:Senile plaques and deposition of intracellular tau fibrils are neuropathological...
Tau pathology is a hallmark of Alzheimer’s disease (AD) but also occurs in normal cognitive aging. U...
Tau pathology is a hallmark of Alzheimer’s disease (AD) but also occurs in normal cognitive aging. U...
Background and aims:[11C]PBB3 is a novel tau imaging PET ligand, showing high affinity and selectivi...
INTRODUCTION:Amyloid-β (Aβ) and tau accumulations may occur independently and concurrently as exempl...
In addition to the deposition of β-amyloid plaques, neurofibrillary tangles composed of aggregated h...
Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pat...
Background: Amyloid-beta (Aβ) is hypothesized to facilitate the spread of tau pathology beyond the m...
Amyloid-β (Aβ) is hypothesized to facilitate the spread of tau pathology beyond the medial temporal ...
Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pat...
Background:We previously reported that among cases clinically diagnosed with Alzheimer’s disease, th...
BackgroundClinical staging of Alzheimer disease (AD) may help develop novel treatment in the early s...
The recent development of tau-specific positron emission tomography (PET) tracers enables in vivo qu...
Tau PET enables in vivo visualization and quantitation of tau accumulation in Alzheimer disease (AD)...